Trivalent, bispecific antibodies

Details for Australian Patent Application No. 2010234031 (hide)

Owner Roche Glycart AG

Inventors Brinkmann, Ulrich; Croasdale, Rebecca; Hoffmann, Eike; Klein, Christian; Moessner, Ekkehard; Schanzer, Juergen Michael; Umana, Pablo

Agent Davies Collison Cave

Pub. Number AU-A-2010234031

PCT Pub. Number WO2010/115589

Priority 09005108.7 07.04.09 EP

Filing date 1 April 2010

Wipo publication date 14 October 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/115589 Priority application(s): WO2010/115589

28 June 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Roche Glycart AG, Application No. 2010234031, under INID (72) add co-inventor Sustmann, Claudio

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234063-Device and method for the verification and quantitative analysis of analytes, particularly mycotoxins

2010234028-Method for purifying recombinant FSH